|
J&J expands
its presence in orthopaedics
US healthcare giant Johnson & Johnson has plans to roll out
India-specific devices soon, in keeping with its plans to expand its presence in
the Indian orthopaedic deices market. These new products will be designed to
suit the Indian market and will be priced economically.
In fact, as a start, J&J recently launched its first product
in this range, a knee implant called PFC Sigma RP-F Knee.
"PFC Sigma very much mimics the natural motion of a knee
joint, which allows patients to do regular activities like bending, kneeling or
playing with children”, said J&J India Director Anil Nayak.
J&J has recognized India as a key growth market for this
business. The company intends to spread awareness amongst patients about
diseases and their management, along with providing training to doctors. J&J
operates its orthopedics devices business through DePuy Orthopaedics and has no
immediate plans to manufacture them in India.
(Reference: Modern Medicare March 2008 )
Transasia Bio-Medicals Ltd. gets ISO 13485
Transasia Bio-Medicals Ltd., a player in the clinical
diagnostics segment in Indian healthcare sector, which aids in diagnosing life
threatening diseases such as AIDS, tuberculosis, cancer, diabetes etc. has been
awarded ISO 13485 ( Quality Management Systems for Medical Devices) by UL India,
a certifying body to foster quality assurance and improvement.
UL India is an affiliate of Underwriters Laboratories Inc.,
USA , which is one of the world’s largest conformity assessment service
provider.
With this certification , Transasia Biomedicals Ltd. becomes
one of the few Indian companies to be awarded the ISO 13485. Transasia claims to
have always recognised quality and R&D as the prime drivers of innovation and
leadership and services to be among the top 10 diagnostic player in the world.
Reference: Modern Medicare March 2008
|
